Gut microbiome, obesity-related comorbidities, and low-grade chronic inflammation

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 7, 2014, Pages 2343-2346

  Tarantino, Giovanni ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA;

BACTEROIDETES; BILE ACID METABOLISM; BILE ACID SYNTHESIS; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; COGNITIVE DEFECT; COMORBIDITY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DIETARY INTAKE; DISEASE COURSE; EDITORIAL; ENERGY METABOLISM; ENVIRONMENTAL FACTOR; EPIGENETICS; ERYSIPELOTHRIX; FIRMICUTES; GAMMAPROTEOBACTERIA; GENOTYPE; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEDENTARY LIFESTYLE; SIGNAL TRANSDUCTION; SLEEP DISORDERED BREATHING; UBIQUITINATION;

BACTERIAL TRANSLOCATION; DNA, BACTERIAL; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; OBESITY, MORBID;

EID: 84904052277     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2074     Document Type: Editorial

References (24)

1. Huang XD, Fan Y, Zhang H, et al. Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World J Gastroenterol. 2008;14:2888-2893.
2. Kopp HP, Kopp CW, Festa A, et al. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23:1042-1047. (Pubitemid 36713558)
3. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science. 1996;274:1379-1383. (Pubitemid 26391463)
4. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J, Paschke R. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2003; Feb 21;301(4):1045-50.
5. Kolak M, Westerbacka J, Velagapudi VR, et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes. 2007;56:1960-1968. (Pubitemid 47195815)
6. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. AnnuRev Immunol. 2000;18:621-663. (Pubitemid 30365393)
7. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes. 2003;52:2784-2789. (Pubitemid 37339708)
8. Cai D, Frantz JD, Tawa NE Jr, et al. IKKβ/NF-κB activation causes severe muscle wasting in mice. Cell. 2004;119:285-298. (Pubitemid 39360909)
9. Arnardottir ES, Maislin G, Schwab RJ, et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep. 2012;35:921-932.
10. Mehra R, Storfer-Isser A, Kirchner HL, et al. Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med. 2006;166:1725-1731. (Pubitemid 44414460)
11. Blaut M, Klaus S. Intestinal microbiota and obesity. Handb Exp Pharmacol. 2012;209:251-273.
12. Flint HJ. Obesity and the gut microbiota. J Clin Gastroenterol. 2011;45:S128-S132.
13. Krznari Z, Vraneši Bender D, Kunovi A, Kekez D, Stimac D. Gut microbiota and obesity. Dig Dis. 2012;30:196-200.
14. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718-15723. (Pubitemid 39473554)
15. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031. (Pubitemid 46018515)
16. Ilan Y. Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol. 2012;18:2609-2618.
17. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761-1772. (Pubitemid 47025442)
18. de Wit N, Derrien M, Bosch-Vermeulen H, et al. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. Am J Physiol Gastrointest Liver Physiol. 2012;303:G589-G599.
19. Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. Association between composition of thehumangastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 2011;140:976-986.
20. Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded? Diabetes Care. 2010;33:2277-2284.
21. Santacruz A, Marcos A, Wärnberg J, et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity (Silver Spring). 2009;17:1906-1915.
22. Osto M, Abegg K, Bueter M, le Roux CW, Cani PD, Lutz TA. Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine. Physiol Behav. 2013;119:92-96.
23. DiBaise JK, Zhang H, Crowell MD, Krajmalnik-Brown R, Decker GA, Rittmann BE. Gut microbiota and its possible relationship with obesity. Mayo Clin Proc. 2008;83:460-469. (Pubitemid 351536471)
24. Ortiz S, Zapater P, Estrada JL, et al. Bacterial DNA translocation holds increased insulin resistance and systemic inflammatory levels in morbid obese patients. J Clin Endocrinol Metab. 2014;99:2575-2583.